Monopoly operation urges the price of raw materials to rocket up

At the symposium of the National People's Congress of the Pharmaceutical Industry and the members of the Chinese People's Political Consultative Conference the day before yesterday, the heads of the Beijing Pharmaceutical Industry Association and some pharmaceutical companies confirmed that the prices of some APIs in my country have risen by about 31 times in less than two years. Behind this staggering figure, the monopoly operation of some generic pharmaceutical raw materials has become an open "secret" in the industry, and it is also a major driver of inflated drug prices.